What Can Non-Surgical Management of CCL Disease Look Like?

When a dog is diagnosed with cranial cruciate ligament (CCL) disease, one of the first conversations owners often have is about surgery. Surgical stabilization can be an excellent treatment option for many dogs, but it isn't the only piece of the CCL conversation-- and for some patients and families, a non-surgical approach may be appropriate.

At Red Sage, non-surgical management doesn't mean simply resting the leg and hoping it gets better. Instead, we look at the whole dog and the disease process occurring within the stifle, then develop an individualized, multimodal plan to improve comfort, strength, mobility, and long-term function.

First, What Is CCL Disease?

The cranial cruciate ligament, or CCL, is an important stabilizing ligament within a dog's knee, or stifle. It is similar in location and function to the ACL in the human knee, but the way these ligaments typically become injured can be very different.

When we hear about a person tearing their ACL, we often picture a sudden sports injury: a hard pivot, an awkward landing, and a previously healthy ligament tears.

In dogs, CCL disease is frequently much more gradual.

One way we like to explain it is to imagine the difference between snapping a glue stick and fraying a braided rope.

A traumatic human ACL injury may behave more like the glue stick: there is a relatively sudden event and the structure fails. A dog's CCL is often more like the braided rope. Individual fibers weaken and fray over time as part of an underlying degenerative process. Eventually, enough fibers are compromised that the ligament partially or completely ruptures and the dog develops obvious lameness.

That distinction is important because by the time we diagnose a CCL tear, we may be looking at more than an isolated ligament injury. There can already be inflammation within the joint, altered biomechanics, muscle loss, compensatory movement patterns, and developing osteoarthritis.

This is why our approach to conservative management is rarely centered around a single treatment. Instead, we ask: How can we support this joint, improve the dog's overall function, and address as many contributors to the disease process as possible?

What About the Other Stifle?

Because CCL disease is often a progressive, degenerative process, we also have to think beyond the stifle that is currently causing clinical signs. Dogs diagnosed with CCL disease in one stifle have a meaningful risk of eventually developing disease in the opposite stifle as well, and research suggests that degenerative changes may already be occurring in that apparently “normal” knee before obvious lameness develops.

This is another reason our approach focuses on the whole dog rather than one injured ligament. While we cannot promise that rehabilitation or any other treatment will prevent disease in the opposite stifle, we can work to maintain an ideal body condition, preserve muscle mass, improve strength and movement quality, and reduce unnecessary compensatory loading throughout the body.

So, What Can CCL Management Look Like at Red Sage?

Shockwave Therapy

Extracorporeal shockwave therapy (ESWT) is one of the modalities we frequently incorporate into non-surgical CCL treatment plans. Despite its name, shockwave is not an electrical shock. It delivers high-energy acoustic pressure waves into targeted tissues, creating a mechanical stimulus that cells convert into biological signals– a process known as mechanotransduction.

On a cellular level, research suggests that shockwave can stimulate several processes involved in tissue repair and remodeling, including:

• Increasing tenocyte and fibroblast activity: These cells play an important role in maintaining and repairing tendons, ligaments, and other connective tissues.

• Stimulating collagen production: Shockwave has been associated with increased production of type I and type III collagen, important components of connective-tissue repair and remodeling.

• Promoting vascular signaling and new blood vessel formation: Increased expression of VEGF and eNOS can encourage angiogenesis, helping improve the vascular environment needed to support tissue repair.

• Increasing healing-related growth factors: Shockwave can influence signaling molecules such as TGF-β1 and IGF-1, which are involved in cell proliferation, collagen synthesis, and tissue remodeling.

• Modulating inflammation and pain: Shockwave also appears to influence nitric oxide and other inflammatory and pain-signaling pathways, which may contribute to improvements in comfort as tissues heal.

In other words, we aren't using shockwave simply to provide temporary pain relief. We're using a mechanical stimulus to encourage a biological response within the tissues.

For a dog with CCL disease, the goal isn't to use shockwave to simply “put the ligament back together.” CCL disease affects the entire joint environment and can involve ligament degeneration, inflammation, altered joint loading, progressive osteoarthritis, muscle loss, and changes to surrounding soft tissues. By stimulating these cellular pathways, our goal is to create a more favorable biological environment for healing and remodeling while improving comfort and function.

Canine studies have investigated ESWT for osteoarthritis and other orthopedic conditions, including disease affecting the stifle, with some demonstrating improvements in objective measures of limb use. The veterinary evidence continues to evolve, which is why we consider shockwave one component of a comprehensive CCL management plan rather than a stand-alone cure.

• 

• 

• 

Why do we recommend a series for shockwave?

Shockwave is typically not a one-and-done therapy. For many CCL patients at Red Sage, we recommend a series of approximately 3–5 treatments, with the exact number and timing individualized to the dog.

One of the most interesting things about shockwave is that the biological response continues long after the treatment itself is over. Experimental studies have shown that cellular changes begin within hours of treatment: markers of tenocyte proliferation can increase within 6–24 hours, followed by increased TGF-β1 and nitric oxide signaling, and increased collagen synthesis in the days that follow. Other experimental tendon studies have demonstrated continued changes in growth-factor signaling, cellular activity, extracellular matrix production, and tissue organization for weeks to months after shockwave application. A systematic review of the tendon literature found evidence of increased TGF-β1 and IGF-1 within six weeks, markers of tenocyte proliferation persisting for up to 12 weeks, and progressive maturation and organization of healing tendon tissue over approximately 16 weeks in some experimental models.

This ongoing response helps explain why shockwave is commonly delivered as a series of treatments rather than a single session. When we perform the next treatment, the tissue may still be actively responding to the biological stimulus created by the previous one. Each subsequent treatment is intended to reinforce and build upon that ongoing healing and remodeling response, providing another mechanical signal while those cellular processes are already underway. Rather than flipping a switch once, think of it as giving the body a series of carefully timed signals encouraging the healing process in the same direction.

And importantly, the biological response to shockwave does not stop after the final treatment. Tissue healing and remodeling continue in the weeks and months that follow, meaning the response we see immediately after the last session may not reflect the dog's full response to therapy. Canine orthopedic studies have documented benefits that persist for several months following a shockwave series, including at six-month follow-up. This continued response is one of the unique benefits of shockwave therapy– the treatment initiates biological processes that continue supporting tissue healing, remodeling, and adaptation long after the final session is complete.

• 

• 

• 

Therapeutic Exercise: Rest Isn't Rehabilitation

It can seem logical that a dog with an injured CCL should simply stop using the leg. Unfortunately, prolonged inactivity comes with its own consequences. When a dog avoids a painful limb, muscle mass and strength can decrease quickly. The dog also begins shifting weight elsewhere, which changes how forces travel through the rest of the body.

A carefully designed rehabilitation program gives us a way to control how the body is loaded rather than eliminating loading altogether.

Depending on the dog and stage of disease, therapeutic exercise may focus on:

• Rebuilding quadriceps, hamstring, gluteal, and core strength

• Improving controlled weight bearing through the affected limb

• Maintaining or improving joint range of motion

• Improving balance and proprioception

• Retraining more symmetrical movement patterns

• Maintaining cardiovascular conditioning

• Strengthening the other three limbs

• Gradually preparing the dog for normal daily activities

Exercises might look deceptively simple: controlled leash walking, backward walking, weight shifting, elevated stands, three-legged stands, cavaletti work, or carefully selected sit-to-stand exercises, but each can be chosen to accomplish a particular biomechanical goal.

And importantly, more exercise is not necessarily better. Running, jumping, rough play, repetitive ball chasing, and sharp turns can place very different forces on an unstable stifle than slow, controlled therapeutic exercises.

The goal is appropriate loading at the appropriate time.

Acupuncture

Acupuncture may also be incorporated into a multimodal CCL plan, particularly when pain, muscle tension, compensatory discomfort, or concurrent orthopedic conditions are present.

Rather than thinking only about the injured stifle, acupuncture allows us to address pain and neuromuscular dysfunction throughout the patient. A dog protecting one knee may develop tension or discomfort through the hips, iliopsoas muscles, back, shoulders, or opposite limbs.

The evidence for acupuncture in canine osteoarthritis is mixed. In a randomized, placebo-controlled clinical trial, acupuncture did not significantly improve objective gait-analysis measurements, but some owner-reported measures of clinical function improved. For us, that makes acupuncture one potential adjunct within a larger treatment plan rather than a stand-alone treatment for CCL disease.

• 

• 

  Electro-acupuncture

• 

Extracorporeal Magnetotransduction Therapy (EMTT)

EMTT is another non-invasive modality that may be incorporated into some treatment plans.

EMTT uses high-energy electromagnetic pulses that penetrate into tissues without needles or surgery. It is being investigated for its potential effects on cellular activity, inflammation, pain, and tissue healing and can be paired with other regenerative and rehabilitation modalities.

Compared with therapies such as therapeutic exercise and shockwave, however, veterinary evidence for EMTT is still very limited. For that reason, we view it as an adjunctive modality rather than a replacement for the more established components of CCL management.

As research evolves, we continue to evaluate where newer technologies may fit within an evidence-informed multimodal treatment plan.

• 

• 

• 

Pulsed Electromagnetic Field (PEMF) Therapy

Pulsed electromagnetic field (PEMF) therapy is a non-invasive modality that uses low-frequency electromagnetic fields to influence cellular activity and support the body’s normal healing processes. In dogs with cranial cruciate ligament (CCL) disease, PEMF may be incorporated into a multimodal treatment plan to help manage pain and inflammation while supporting tissue recovery. One advantage of PEMF is that it can be delivered in several different ways depending on the treatment goal. In our clinic, we use Respond Systems PEMF beds, which allow a dog to lie comfortably within a larger electromagnetic field and are particularly useful when treating broader areas or providing whole-body support.

For at-home treatment, we often send patients home with HealFast PEMF loops, which create a smaller, more localized field that can be positioned around the affected stifle. Other wearable devices, such as the Assisi Loop, work on a similar general principle and are designed for convenient, targeted treatment at home. Unlike a PEMF bed, which exposes a larger portion of the body to the field, loops concentrate treatment around a specific region and can therefore be especially practical for ongoing management of an affected knee.

Manual Therapy and Massage

Sometimes the knee isn't the only thing that hurts.

Dogs with CCL disease frequently change how they stand and move. Over time, those compensations can contribute to tight or painful muscles and altered mobility elsewhere in the body.

Massage and manual therapy can be used to address those secondary changes. Depending on the patient, treatment might focus on muscle tension, soft-tissue mobility, joint range of motion, or areas that have become overloaded as the dog compensates for the affected stifle.

Manual therapy doesn't stabilize a CCL-deficient knee. Instead, it can help us keep the rest of the dog moving and feeling as well as possible while we address the primary disease.

• 

• 

• 

Regenerative Medicine and Joint Injections

Regenerative medicine and injectable therapies can be valuable components of a non-surgical CCL management plan, particularly when the goal is to improve joint comfort, support the health of the tissues within and around the stifle, and address the inflammation and osteoarthritis that can develop secondary to chronic joint instability.

Platelet-rich plasma (PRP) is created from a patient’s own blood and concentrates platelets and growth factors that can help regulate inflammation and support the body’s natural healing processes. Stem cell therapy, typically using cells harvested from the patient’s own bone marrow or adipose tissue, may also be used to help modulate inflammation and support a healthier joint environment in patients with osteoarthritis and other musculoskeletal disease.

Other intra-articular options include products such as Arthramid, a polyacrylamide hydrogel that integrates with the synovial lining and is designed to provide longer-term support within the joint, and Spryng, an injectable extracellular matrix product designed to provide structural support within and around affected tissues. These products work differently from biologic therapies such as PRP and stem cells but can similarly be incorporated into a multimodal approach to improving joint comfort and function.

The most appropriate therapy depends on the individual patient, degree of CCL injury and instability, presence of osteoarthritis, activity level, and treatment goals. While regenerative medicine and joint injections do not replace the mechanical function of an intact CCL, they can be valuable tools alongside rehabilitation, controlled exercise, weight management, and other pain-management strategies as part of a comprehensive conservative treatment plan.

• 

• 

• 

Nutrition and Joint Support

Nutrition is another important, and highly individualized, part of conservative CCL management. Maintaining an ideal body condition is particularly important for dogs with orthopedic disease. Every unnecessary pound increases the mechanical demand placed on an already compromised joint.

Beyond calories and body condition, we may also discuss targeted nutritional supplements. There isn't one universal "joint supplement" that every CCL patient needs, and more supplements are not necessarily better. We select products based on the individual dog's diet, medical history, medications, concurrent orthopedic disease, and goals.

Some options we may consider include:

Omega-3 fatty acids (EPA and DHA)

Marine-derived omega-3 fatty acids can help modulate inflammatory pathways. Canine osteoarthritis studies have demonstrated improvements in measures including weight bearing and clinical mobility in dogs receiving omega-3-enriched diets.

Undenatured type II collagen (UC-II®)

UC-II works differently from simply supplying collagen as a building block. It is thought to act through oral tolerance and immune modulation directed toward type II collagen, an important component of joint cartilage. Clinical studies in dogs with osteoarthritis have reported improvements in mobility and clinical scores with UC-II supplementation.

Curcumin

Curcumin, a component of turmeric, has been investigated for its effects on inflammatory pathways. Bioavailability is an important consideration because standard curcumin is poorly absorbed, which is one reason specialized formulations such as curcumin phytosome may be used. Canine research involving curcuminoid-containing nutritional interventions has demonstrated some improvements in pain-related outcomes, although evidence for specific formulations varies.

Muscle-support supplements (MYOS® and Ursolyx®)

Maintaining muscle mass is particularly important in dogs with CCL disease. Pain and reduced use of the affected limb can quickly lead to muscle loss, especially in the quadriceps and other muscles that help support and dynamically stabilize the stifle. Products such as MYOS and Ursolyx may be incorporated into a rehabilitation plan to help support muscle health and preservation. MYOS contains Fortetropin, a fertilized egg-yolk-derived ingredient studied for its effects on muscle mass and muscle protein metabolism in dogs. Ursolyx contains ursolic acid, a naturally occurring plant compound used to support muscle strength and healthy body composition. These products do not replace progressive therapeutic exercise, but may provide additional nutritional support while we work to rebuild and maintain muscle.

Multi-ingredient joint supplements

Products such as Movoflex combine several ingredients intended to support different aspects of joint health. Whether a combination product or individual supplementation makes the most sense depends on the patient.

Supplements are just that– supplements to a larger treatment plan. They don't replace appropriate pain management, rehabilitation, weight management, or stabilization when surgery is indicated.

Pain Management

Effective pain management is an essential part of non-surgical CCL care. Pain and inflammation can cause dogs to avoid using the affected limb, leading to compensatory movement patterns, muscle loss, weakness, and increased stress on the other limbs and joints. Keeping a dog comfortable is therefore about more than simply reducing pain—it helps them move more normally and participate successfully in the controlled exercise and rehabilitation needed to rebuild strength and function.

Pain management should be individualized and may include anti-inflammatory medications (NSAIDs), other prescription pain medications, supplements, weight management, and rehabilitation modalities such as laser therapy, shockwave therapy, acupuncture, or PEMF. These approaches are often used together as part of a multimodal pain-management plan, allowing us to address pain through several different pathways rather than relying on a single treatment.

Importantly, pain control does not mean encouraging unrestricted activity before the knee is ready. A dog may feel significantly better before adequate strength and stability have been restored, so activity should still be progressed gradually and intentionally. The goal is to keep the patient comfortable enough to move well, maintain muscle, and participate in rehabilitation while the body adapts and we work toward the best possible long-term function.

• 

• 

• 

• 

• 

• 

There Is No Single "CCL Protocol"

Perhaps the most important part of conservative CCL management is that it should not look identical for every dog.

A young athletic dog with a partial tear has very different needs from an older dog with a complete tear and advanced osteoarthritis. Body condition, muscle mass, degree of instability, meniscal involvement, activity level, other orthopedic conditions, medical history, and the family's goals all influence what we recommend.

For one patient, treatment might emphasize rehabilitation, weight management, and shockwave therapy. Another may benefit from acupuncture, nutritional support, medication, regenerative medicine, or additional pain-management strategies.

And sometimes, despite our best conservative efforts, surgery remains the best option. Choosing to begin with non-surgical management does not mean that surgery can never be considered later.

Our goal is not simply to treat a torn ligament.

Our goal is to treat the dog living with cruciate disease.